Justyna Osmulska

Prevention of epilepsy, based on the findings of Nencki Institute’s scientists is already in clinical trials

This innovative therapy is designed to protect against the development of post-traumatic and post-stroke epilepsy. It is based on the research results on the role of MMP-9 enzyme in the process of epileptogenesis, by Prof. Leszek Kaczmarek and his team at the Laboratory of Neurobiology of the Nencki Institute. The laboratory operates within the Center of Excellence for Neural Plasticity and Brain Disorders BRAINCITY. Pikralida Sp. z o. o., the licensee of the rights to the invention of ...

SPARK Europe Webinar Series 2023

Regulatory landscape for medical devices - how to approve your solution quickly in Europe or should you focus on the US market 8th November 2023 | 16-17 CET | online webinar   If ...

3rd Ultrasonic Vocalization Conference

We have the pleasure of inviting you to the 3rd Ultrasonic Vocalization Conference to be held at the Nencki Institute on the 26th and 27th of October 2023 between 10:00-18:00 CET. It’s a ...

Nencki Institute Seminar

Dear All I would like to warmly invite you to our next Nencki Institute Seminar on the 26th of October at 3pm in the CN lecture hall. We will host prof. Khanh Huy Bui. Prof. Bui’s lecture will ...

Nencki Foundation Lecture (in Polish)

Wykład dr Małgorzata Gut pt.: „Gry komputerowe jako pomoc w edukacji matematycznej i metoda terapii w dyskalkulii” obędzie się 25 października 2023 r. wyjątkowo o godz. 17:00 na platformie na ...